Related Experiment Video
Updated: Aug 14, 2026

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
[The appropriate use of clinical biological tests in hypercoagulability]
1Service de Biologie Clinique, Centre Hospitalier Etterbeek-Ixelles, Bruxelles.
Abstract:
Biological markers who are associated with hypercoagulability are of two types: Markers of activation: among them, the most interesting are the D-dimers which are good tools of diagnostic for the deep venous thrombosis and the pulmonary embolism. Thanks to their high negative predictive value. Etiological factors of hypercoagulable states and thrombosis, in other words: the "hypercoagulability chek up". This one should never be systematic. We propose either to practice it one month after the end of the anticoagulant therapy or to make it with prophylactic doses of low molecular weight heparin and far from the thrombotic episode.
More Related Videos
04:56Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care